The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), ProPhase Labs's share price is $4.71. ProPhase Labs's Book Value per Share for the quarter that ended in Dec. 2023 was $2.74. Hence, ProPhase Labs's PB Ratio of today is 1.72.
The historical rank and industry rank for ProPhase Labs's PB Ratio or its related term are showing as below:
PRPH'
s PB Ratio Range Over the Past 10 Years
Min: 0.64 Med: 2.1 Max: 17.58
Current: 1.72
During the past 13 years, ProPhase Labs's highest PB Ratio was 17.58. The lowest was 0.64. And the median was 2.10.
PRPH's PB Ratio is ranked better than 56.19% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.055
vs PRPH: 1.72
During the past 12 months, ProPhase Labs's average Book Value Per Share Growth Rate was -30.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 44.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 28.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 20.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ProPhase Labs was 115.80% per year. The lowest was -31.70% per year. And the median was -3.80% per year.
Back to Basics: PB Ratio
ProPhase Labs PB Ratio Historical Data
The historical data trend for ProPhase Labs's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ProPhase Labs's PB Ratio
For the Diagnostics & Research subindustry, ProPhase Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProPhase Labs's PB Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's PB Ratio distribution charts can be found below:
* The bar in red indicates where ProPhase Labs's PB Ratio falls into.
ProPhase Labs PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
ProPhase Labs's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
ProPhase Labs PB Ratio Related Terms
Thank you for viewing the detailed overview of ProPhase Labs's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ProPhase Labs (ProPhase Labs) Business Description
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRPH has been successfully added to your 